Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1947]
News [3614]
Articles [95]
Editorials [5]
Conferences [157]
elearning [19]
ZUMA-5 update: Axicabtagene ciloleucel continues to show strong effect in R/R...
Prof Sattva Neelapu - The University of Texas MD Anderson Cancer Center...
ZUMA-5 update: Axicabtagene ciloleucel continues to show strong effect in R/R iNHL ( Prof Sattva Neelapu - The University of Texas MD Anderson Cancer Center, Houston, USA )
11 Dec 2021
Lisocabtagene maraleucel demonstrates improvement over standard of care in 2L...
Dr Manali Kamdar - The University of Colorado Anschutz Medical Campus, Aurora...
Lisocabtagene maraleucel demonstrates improvement over standard of care in 2L LBCL ( Dr Manali Kamdar - The University of Colorado Anschutz Medical Campus, Aurora, USA )
11 Dec 2021
Latest in advanced endometrial cancer
Prof Isabelle Ray-Coquard, Prof Christian Marth, Prof David Cibula, Prof Ignace...
Latest in advanced endometrial cancer ( Prof Isabelle Ray-Coquard, Prof Christian Marth, Prof David Cibula, Prof Ignace Vergote )
9 Dec 2021
Post-HSCT management of ALL - Adult ALL perspective
Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain
Post-HSCT management of ALL - Adult ALL perspective ( Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain )
6 Dec 2021
Safety profile of BiTE therapy
Dr Arend von Stackelberg - Charité Universitätsmedizin, Berlin, Germany
Safety profile of BiTE therapy ( Dr Arend von Stackelberg - Charité Universitätsmedizin, Berlin, Germany )
2 Dec 2021
Cancer drug policy and access in LMICs
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Cancer drug policy and access in LMICs ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
26 Nov 2021
Anti-CD38 immunotherapy treatment for multiple myeloma
Prof Xavier Leleu - CHU de Poitiers, Poitiers, France
Anti-CD38 immunotherapy treatment for multiple myeloma ( Prof Xavier Leleu - CHU de Poitiers, Poitiers, France )
22 Nov 2021
Paediatric ALL perspective
Prof Andrea Biondi - University of Milano-Bicocca, Milan, Italy
Paediatric ALL perspective ( Prof Andrea Biondi - University of Milano-Bicocca, Milan, Italy )
12 Nov 2021
Immunotherapy of T-ALL: Opportunities and hurdles
Dr Maksim Mamonkin - Baylor College of Medicine, Houston, USA
Immunotherapy of T-ALL: Opportunities and hurdles ( Dr Maksim Mamonkin - Baylor College of Medicine, Houston, USA )
10 Nov 2021
Managing immune-related adverse effects in Africa
Dr Mohammed Ezzi- University of Nairobi, Nairobi, Kenya
Managing immune-related adverse effects in Africa ( Dr Mohammed Ezzi- University of Nairobi, Nairobi, Kenya )
10 Nov 2021
What to look forward to at AORTIC 2021
Dr Nazik Hammad - Queen's University, Kingston, Canada
What to look forward to at AORTIC 2021 ( Dr Nazik Hammad - Queen's University, Kingston, Canada )
3 Nov 2021
Identifying and treating high-risk/MRD positive newly diagnosed multiple myeloma
Prof Wee Joo Chng - National University Cancer Institute, Singapore
Identifying and treating high-risk/MRD positive newly diagnosed multiple myeloma ( Prof Wee Joo Chng - National University Cancer Institute, Singapore )
29 Oct 2021

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation